A Phase II Randomized Trial of Gefitinib Alone vs Olaparib Plus Gegitinib in Advanced NSCLC EGFRmut plus Goal Trial Spanish Lung Cancer Group
Por:
Massuti, B, Campelo, RG, Arrieta, O, Rodriguez-Abreu, D, Granados, ALO, Majem, M, Baz, DV, Lianes, P, Barrera, JB, Insa, A, Domine, M, Reguart, N, Guirado, M, Sala, M, Vazquez, S, Bernabe, R, Macias, JA, Palmero, R, Verdu, A, Drozdowskyj, A and Rosell, R
Publicada:
1 nov 2017
Resumen:
Filiaciones:
Massuti, B:
Alicante Univ Hosp, Med Oncol, Alicante, Spain
Campelo, RG:
Hosp Teresa Herrera, La Coruna, Spain
Arrieta, O:
Natl Canc Inst, Lab Expt Oncol, Mexico City, DF, Mexico
Natl Canc Inst, Thorac Oncol Unit, Mexico City, DF, Mexico
Rodriguez-Abreu, D:
Hosp Univ Insular Gran Canaria, Med Oncol, Las Palmas, Mexico
Granados, ALO:
Complejo Hosp Jaen, Med Oncol, Jaen, Spain
Majem, M:
Hop La Santa Creu & St Pau, Barcelona, Spain
Baz, DV:
Hosp Virgen Macarena, Med Oncol, Seville, Spain
Lianes, P:
Hosp Mataro, Mataro, Spain
Barrera, JB:
Hosp Univ Dr Josep Trueta, Catalan Inst Oncol, Girona, Spain
Insa, A:
Hosp Clin Valencia, Valencia, Spain
Domine, M:
Hosp Univ Fdn Jimenez Diaz, Oncol, Madrid, Spain
Reguart, N:
Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
Guirado, M:
Hosp Gen Elche, Elche, Spain
Sala, M:
Hosp Basurto, Bilbao, Spain
Vazquez, S:
Hosp Univ Lucus Augusti, Lugo, Spain
Bernabe, R:
Hosp Univ Valme, Seville, Spain
Macias, JA:
Hosp Morales Meseguer, Murcia, Spain
Palmero, R:
ICO Hosp Duran & Reynals, Barcelona, Spain
Verdu, A:
Gecp, Barcelona, Spain
Drozdowskyj, A:
Pivotal, Madrid, Spain
:
Germans Trias & Pujol Hlth Sci Inst & Hosp, Catalan Inst Oncol, Canc Biol & Precis Med Program, Barcelona, Spain
|